Click here to close now.

SYS-CON MEDIA Authors: Pat Romanski, Rex Morrow, Datical, Liz McMillan, John Wetherill, Ruxit Blog

News Feed Item

Tremor Global Clinical Trials Review, H2, 2014

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Tremor Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312347/Tremor-Global-Clinical-Trials-Review-H2-2014.html

Tremor Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Tremor Global Clinical Trials Review, H2, 2014" provides data on the Tremor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tremor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tremor. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Tremor 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Tremor to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Tremor to Central Nervous System Clinical Trials 16
Clinical Trials by Phase 17

In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Tremor 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Tremor Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Veloxis Pharmaceuticals A/S 27
Clinical Trial Overview of Veloxis Pharmaceuticals A/S 27
Clinical Trial Overview of Top Institutes / Government 28
University of Alabama at Birmingham 28
Clinical Trial Overview of University of Alabama at Birmingham 28
National Institute of Neurological Disorders and Stroke 29
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 29
Boston Children's Hospital 30
Clinical Trial Overview of Boston Children's Hospital 30
Ohio State University 31

Clinical Trial Overview of Ohio State University 31
Emory University 32
Clinical Trial Overview of Emory University 32
Mayo Clinic 33
Clinical Trial Overview of Mayo Clinic 33
Syracuse University 34
Clinical Trial Overview of Syracuse University 34
Yazd Medical University 35
Clinical Trial Overview of Yazd Medical University 35
Mount Sinai Hospital 36
Clinical Trial Overview of Mount Sinai Hospital 36
University of California, Davis 37
Clinical Trial Overview of University of California, Davis 37
Five Key Clinical Profiles 38
Appendix 59
Abbreviations 59
Definitions 59
Research Methodology 60
Secondary Research 60
About GlobalData 61
Contact Us 61
Disclaimer 61
Source 61

List of Tables
Tremor Therapeutics, Global, Clinical Trials by Region, 2014* 6
Tremor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Tremor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Tremor Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Tremor Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Tremor Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Tremor Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Tremor to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Tremor Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Tremor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Tremor to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Tremor Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Tremor Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Tremor Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Tremor Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Tremor Therapeutics, Global, Terminated Clinical Trials, 2014* 21
Tremor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Tremor Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Tremor Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Tremor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Tremor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Veloxis Pharmaceuticals A/S, 2014* 27
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2014* 28
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 29
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2014* 30

Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University, 2014* 31
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 32
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 33
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Syracuse University, 2014* 34
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Yazd Medical University, 2014* 35
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai Hospital, 2014* 36
Tremor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2014* 37

List of Figures
Tremor Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Tremor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Tremor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Tremor Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9

Proportion of Tremor to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Tremor Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Tremor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Tremor to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Tremor Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Tremor Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Tremor Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Tremor Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Tremor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Tremor Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Tremor Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Tremor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 60

Read the full report:
Tremor Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2312347/Tremor-Global-Clinical-Trials-Review-H2-

2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com  
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
IBM has acquired Blue Box Group, Inc., a managed private cloud provider built on OpenStack. Customers benefit from the ability to more easily deploy workloads across hybrid cloud environments. Financial details were not disclosed. Enterprises are seeking ways to embrace all types of cloud to address a wide range of workloads. Today's announcement reinforces IBM's commitment to deliver flexible cloud computing models that make it easier for customers to move to data and applications across cloud...
ProfitBricks has an early preview of its new Docker hosting platform. The ProfitBricks Docker platform enables its customers to build fully-portable applications within the ProfitBricks cloud. Unlike other Docker platforms, ProfitBricks’ Docker provides developers and system administrators with a platform with dedicated resources that autoscales the Docker hosts. Early access customers will be able to utilize up to 2,500 CPU core hours as part of ProfitBricks’ early access Docker preview.
2015 predictions circa 1970: houses anticipate our needs and adapt, city infrastructure is citizen and situation aware, office buildings identify and preprocess you. Today smart buildings have no such collective conscience, no shared set of fundamental services to identify, predict and synchronize around us. LiveSpace and M2Mi are changing that. LiveSpace Smart Environment devices deliver over the M2Mi IoT Platform real time presence, awareness and intent analytics as a service to local connecte...
The Internet of Things is not only adding billions of sensors and billions of terabytes to the Internet. It is also forcing a fundamental change in the way we envision Information Technology. For the first time, more data is being created by devices at the edge of the Internet rather than from centralized systems. What does this mean for today's IT professional? In this Power Panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists will addresses this very serious issue o...
paradigm shifts in networking, to cloud and licensure, and all the Internet of Things in between. In 2014 automation was the name of the game. In his session at DevOps Summit, Matthew Joyce, a Sales Engineer at Big Switch, will discuss why in 2015 it’s complexity reduction. Matthew Joyce, a sales engineer at Big Switch, is helping push networking into the 21st century. He is also a hacker at NYC Resistor. Previously he worked at NASA Ames Research Center with the Nebula Project (where OpenSta...
While there are hundreds of public and private cloud hosting providers to choose from, not all clouds are created equal. If you’re seeking to host enterprise-level mission-critical applications, where Cloud Security is a primary concern, WHOA.com is setting new standards for cloud hosting, and has established itself as a major contender in the marketplace. We are constantly seeking ways to innovate and leverage state-of-the-art technologies. In his session at 16th Cloud Expo, Mike Rivera, Seni...
"Verizon Digital Media Services is responsible for the broadcast, video and content delivery network that accelerates, scales and helps our customers reach end users with all kinds of video and web content," stated James Segil, CMO of Verizon Digital Media Services, in this SYS-CON.tv interview at 15th Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
"For over 25 years we have been working with a lot of enterprise customers and we have seen how companies create applications. And now that we have moved to cloud computing, mobile, social and the Internet of Things, we see that the market needs a new way of creating applications," stated Jesse Shiah, CEO, President and Co-Founder of AgilePoint Inc., in this SYS-CON.tv interview at 15th Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
The most often asked question post-DevOps introduction is: “How do I get started?” There’s plenty of information on why DevOps is valid and important, but many managers still struggle with simple basics for how to initiate a DevOps program in their business. They struggle with issues related to current organizational inertia, the lack of experience on Continuous Integration/Delivery, understanding where DevOps will affect revenue and budget, etc. In their session at DevOps Summit, JP Morgentha...
Health care systems across the globe are under enormous strain, as facilities reach capacity and costs continue to rise. M2M and the Internet of Things have the potential to transform the industry through connected health solutions that can make care more efficient while reducing costs. In fact, Vodafone's annual M2M Barometer Report forecasts M2M applications rising to 57 percent in health care and life sciences by 2016. Lively is one of Vodafone's health care partners, whose solutions enable o...
The world is at a tipping point where the technology, the device and global adoption are converging to such a point that we will see an explosion of a world where smartphone devices not only allow us to talk to each other, but allow for communication between everything – serving as a central hub from which we control our world – MediaTek is at the heart of both driving this and allowing the markets to drive this reality forward themselves. The next wave of consumer gadgets is here – smart, con...
The multi-trillion economic opportunity around the "Internet of Things" (IoT) is emerging as the hottest topic for investors in 2015. As we connect the physical world with information technology, data from actions, processes and the environment can increase sales, improve efficiencies, automate daily activities and minimize risk. In his session at @ThingsExpo, Ed Maguire, Senior Analyst at CLSA Americas, will describe what is new and different about IoT, explore financial, technological and re...
"At Harbinger we do products as well as services. Our services are with helping companies move their products to the cloud operating systems. Some of the challenges we have seen as far as cloud adoption goes are in the cloud security space," noted Shrikant Pattathil, Executive Vice President at Harbinger Systems, in this SYS-CON.tv interview at Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
"At our booth we are showing how to provide trust in the Internet of Things. Trust is where everything starts to become secure and trustworthy. Now with the scaling of the Internet of Things it becomes an interesting question – I've heard numbers from 200 billion devices next year up to a trillion in the next 10 to 15 years," explained Johannes Lintzen, Vice President of Sales at Utimaco, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4–6, 2014, at the Santa Clara Convention Center in San...
Aria Systems, which helps enterprises grow recurring revenue, today announced that its co-founder and inventor of cloud billing Brendan O'Brien, will be a featured speaker at the Cloud Expo, June 9-11 at The Javits Center in New York. Aria also will be demonstrating its Active Monetization platform in Booth #424 on the Expo Floor. O'Brien will lead the following sessions: June 9 - 11:00 am - 11:35 am, Room 1A16 with participants from Constant Contact, MGI Research and ATG Enabling Complex ...